Overview
Phosphorex is a leading contract development and manufacturing organization (CDMO) located just 26.2 miles from Boston in Hopkinton, MA. Our state-of-the-art facility spans 30,000 sq. ft., with an additional 12,000 sq. ft. of cGMP space set to come online in early 2025.
With our expertise and innovative technologies, we excel in encapsulating drugs into microspheres or nanoparticles, enabling targeted delivery, protection of therapeutic agents, controlled release, and improved bioavailability. From proof-of-concept to clinical studies, our integrated solution supports all phases of formulation development.
Our team of technical experts brings extensive experience in various areas, including:
- Lipid Nanoparticles (LNPs) for Nucleic Acid Delivery
- Polymeric Nanoparticles (PNPs) for Targeted Delivery
- Polymeric Microspheres for Sustained-Release Delivery
At Phosphorex, we are committed to pushing the boundaries of drug delivery, delivering superior solutions, and driving the success of our clients.
Company News
Technical Bulletin | Reducing the Variability of the RiboGreen® Assay
Aug 19, 2024
Posted by Phosphorex
Phosphorex Welcomes NOF CORPORATION as Shareholder and Strategic Partner
Aug 14, 2024
Posted by Phosphorex